Single institution experience of recombinant activated factor VII (Novo-Seven) in the management of intractable bleeding in surgical and trauma patients.

被引:0
|
作者
Alcorn, K
Aggarwal, A
机构
[1] Washington Hosp Ctr, Dept Pathol, Washington, DC 20010 USA
[2] Washington Hosp Ctr, Dept Hematol & Oncol, Washington, DC 20010 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3840
引用
收藏
页码:91B / 91B
页数:1
相关论文
共 50 条
  • [1] Use of recombinant activated factor VII (rFVIIa) in the management of intractable bleeding in surgical and trauma patients.
    Aggarwal, A
    Catlett, J
    Alcorn, K
    BLOOD, 2001, 98 (11) : 66B - 66B
  • [2] Clinical experience with recombinant activated factor VII for severe intractable bleeding
    Oliveri, CV
    Manale, SB
    Han, MC
    Stubbs, JR
    TRANSFUSION, 2003, 43 (09) : 4A - 5A
  • [3] Recombinant activated coagulation factor VII and bleeding trauma patients
    Rizoli, Sandro B.
    Nascimento, Bartolomeu, Jr.
    Osman, Fahima
    Netto, Fernando Spencer
    Kiss, Alex
    Callum, Jeannie
    Brenneman, Frederick D.
    Tremblay, Lorraine
    Tien, Homer C.
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2006, 61 (06): : 1419 - 1425
  • [4] The role of recombinant-activated factor VII in bleeding trauma patients
    Dutton, Richard P.
    Conti, Bianca M.
    CURRENT OPINION IN ANESTHESIOLOGY, 2009, 22 (02) : 299 - 304
  • [5] Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
    Klitgaard, Thomas
    Palacios, Rene Tabanera y
    Boffard, Kenneth D.
    Lau, Philip T. C.
    Warren, Brian
    Rizoli, Sandro
    Rossaint, Rolf
    Kluger, Yoram
    Riou, Bruno
    CRITICAL CARE, 2006, 10 (04):
  • [6] Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
    Thomas Klitgaard
    Rene Tabanera y Palacios
    Kenneth D Boffard
    Philip TC Iau
    Brian Warren
    Sandro Rizoli
    Rolf Rossaint
    Yoram Kluger
    Bruno Riou
    Critical Care, 10
  • [7] Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
    E Shulutko
    V Gorodetsky
    Critical Care, 10 (Suppl 1):
  • [8] Recombinant activated factor VII (rVIIa): Predicting response in intractable bleeding
    Miall, FM
    Barton, LM
    Ayyash, R
    Tadd, SE
    Pavord, SR
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 20 - 20
  • [9] Recombinant activated factor VII for intractable bleeding postsplenectomy in a patient with myeloproliferative disorder
    El Kinge, Abdul Rahman D.
    Mahfouz, Rami A.
    Shamseddine, Ali I.
    Taher, Ali T.
    BLOOD COAGULATION & FIBRINOLYSIS, 2007, 18 (06) : 577 - 579
  • [10] Effect of Recombinant Activated Factor VII in Critical Bleeding: Clinical Experience of a Single Center
    Sartori, Maria Teresa
    Imbergamo, Silvia
    Zanon, Ezio
    Bonaccorso, Giuseppina
    Pittoni, Giovanni
    Feltracco, Paolo
    Ori, Carlo
    Pagnan, Antonio
    Cella, Giuseppe
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2009, 15 (06) : 628 - 635